Search for: "KV Pharmaceuticals" Results 21 - 40 of 92
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2008, 9:40 pm
KV Pharmaceutical Co. 1:08-cv-00223; filed April 18, 2008 in the District Court of Delaware... [read post]
4 Aug 2008, 4:39 am
KV Pharm., No. 07-4819 (D.N.J. 2008) KV Pharmaceutical filed an ANDA for a generic version of Ritalin LA (methylphenidate HCl extended-release capsules) with paragraph IV certifications to Celgene's U.S. [read post]
10 Mar 2011, 8:55 am
Manufactured by KV Pharmaceuticals, if you want the drug today it is $20 per injection.Next week it will be $1500.A drug for high-risk pregnant women has cost about $10 to $20 per injection. [read post]
19 Apr 2011, 4:30 am by Frances G. Zacher
As KV Pharmaceutical pointed out to The Washington Post, the company is spending approximately $200 million developing the drug and having it approved by the FDA. [read post]
6 Feb 2009, 3:18 pm
According to an FDA press release, Ethex Corporation, a division of KV Pharmaceutical, recalled the painkiller Dec. 23 because the manufactured pills were larger than intended. [read post]
12 Oct 2009, 12:38 pm
Citigroup Global Market, Inc. has filed a motion to dismiss an action against it by KV Pharmaceuticals Co. arising out of sales of auction rate securities, according to an August 25 article in Law360 by Christine Caufield entitled "Citigroup Argues KV Pharma Knew ARS Risks. [read post]
25 Feb 2010, 2:18 pm by Tom Lamb
From a February 25, 2010 article, "KV Pharmaceutical to plead guilty, pay $27.6M, close generics business", published by the St. [read post]
23 Jun 2008, 2:54 am
KV Pharmaceutical Co. 3:08-cv-03012; filed June 17, 2008 in the District Court of New Jersey Infringement of U.S. [read post]
31 May 2009, 8:12 pm
KV Pharmaceutical Co. 1:09-cv-00376; filed May 28, 2009 in the District Court of Delaware Infringement of U.S. [read post]
6 Sep 2012, 5:25 pm by FDABlog HPM
District Court for the District of Columbia dealt a blow to K-V Pharmaceutical Company’s (“KV’s”) efforts to “restore” orphan drug exclusivity for the pre-term birth drug MAKENA (hydroxyprogesterone caproate) Injection, 250 mg/mL, by granting FDA’s Motion to Dismiss a case filed by KV back in early July. [read post]
19 Jan 2011, 12:26 pm by Bexis
KV Pharmaceutical Co., No. 10-1326, slip op. [read post]
18 Jan 2010, 1:02 pm by Page Perry LLC
Two months ago we reported that Citigroup Global Markets, Inc. had asked a New York court to dismiss a $72 million lawsuit filed against it by KV Pharmaceutical Co. [read post]
12 Dec 2011, 1:21 pm by fraudfighters
  KV Pharmaceutical Company has agreed to pay $17 million to resolve allegations in a lawsuit brought by the Government against one of its former subsidiaries, Ethex Corporation. [read post]
10 Mar 2011, 7:58 am by Maxwell Kennerly
That's a big win for patients out there and a big loss for KV Pharmaceuticals, but it might not be the end of it. [read post]
29 Oct 2006, 7:43 pm
Harper KV Pharmaceutical Company recently filed a citizen petition asking the FDA to relist U.S. [read post]
4 Sep 2009, 12:11 pm
KV Pharmaceutical Company, C.A. 08-223-JJF (D. [read post]
6 May 2010, 7:10 am by Carey, Danis & Lowe
Last month, I wrote about the legal and financial troubles at Ethex Corp., whose parent company is KV Pharmaceuticals here in St. [read post]
5 Aug 2008, 1:58 pm
Here's a quote from the judgment:If this Court were to grant KV's motion, it would put pharmaceutical patent owners in an untenable position. [read post]